Cargando…

Expression of CD1d by astrocytes corresponds with relative activity in multiple sclerosis lesions

The CD1 protein family present lipid antigens to the immune system. CD1d has been observed in the CNS of MS patients, yet no studies have quantitatively characterized this expression and related it to inflammatory demyelinative activity in MS plaques. In this study, we set out to localize and quanti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muir, Fraser G.W., Samadi‐Bahrami, Zahra, Moore, George R. Wayne, Quandt, Jacqueline A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916356/ https://www.ncbi.nlm.nih.gov/pubmed/31050367 http://dx.doi.org/10.1111/bpa.12733

Ejemplares similares

Multiple Sclerosis: Destruction and Regeneration of Astrocytes in Acute Lesions
por: Prineas, John W, et al.
Publicado: (2019)

The landscape of myeloid and astrocyte phenotypes in acute multiple sclerosis lesions
por: Park, Calvin, et al.
Publicado: (2019)

Lesion-level correspondence and longitudinal properties of paramagnetic rim and slowly expanding lesions in multiple sclerosis
por: Elliott, Colm, et al.
Publicado: (2023)

The Role of Astrocytes in Multiple Sclerosis
por: Ponath, Gerald, et al.
Publicado: (2018)

The Role of Astrocytes in Multiple Sclerosis Progression
por: Correale, Jorge, et al.
Publicado: (2015)

Mucosal Administration of E-selectin Limits Disability in Models of Multiple Sclerosis
por: Quandt, Jacqueline A., et al.
Publicado: (2019)

BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma
por: Krumbholz, Markus, et al.
Publicado: (2005)

Correspondence
por: Muir, E.
Publicado: (1921)

Correspondence
por: Muir, John R.
Publicado: (1896)

Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes
por: Perriard, Guillaume, et al.
Publicado: (2015)

Microglia and Astrocytes in Neuro-Aids, Alzheimers Disease, and Multiple Sclerosis
por: Minagar, Alireza, et al.
Publicado: (2001)

Astrocyte Heterogeneity in Multiple Sclerosis: Current Understanding and Technical Challenges
por: Lo, Chih Hung, et al.
Publicado: (2021)

Astrocytes in Multiple Sclerosis—Essential Constituents with Diverse Multifaceted Functions
por: Aharoni, Rina, et al.
Publicado: (2021)

Therapeutic Potential of Astrocyte Purinergic Signalling in Epilepsy and Multiple Sclerosis
por: Nobili, Paola, et al.
Publicado: (2022)

Astrocytes Undergo Metabolic Reprogramming in the Multiple Sclerosis Animal Model
por: das Neves, Sofia Pereira, et al.
Publicado: (2023)

Multiple sclerosis patients’ response to COVID-19 pandemic and vaccination: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Expression of the neuroprotective protein aryl hydrocarbon receptor nuclear translocator 2 correlates with neuronal stress and disability in models of multiple sclerosis
por: Rahim, Tissa, et al.
Publicado: (2018)

Astrocytes and Inflammatory T Helper Cells: A Dangerous Liaison in Multiple Sclerosis
por: Kunkl, Martina, et al.
Publicado: (2022)

Neurogenesis in the chronic lesions of multiple sclerosis
por: Chang, Ansi, et al.
Publicado: (2008)

Oxidative damage in multiple sclerosis lesions
por: Haider, Lukas, et al.
Publicado: (2011)

Tractography in the presence of multiple sclerosis lesions
por: Lipp, Ilona, et al.
Publicado: (2020)

Vitamin D/CD46 Crosstalk in Human T Cells in Multiple Sclerosis
por: Killick, Justin, et al.
Publicado: (2020)

Expression Pattern of Myelin-Related Apolipoprotein D in Human Multiple Sclerosis Lesions
por: Navarro, Ana, et al.
Publicado: (2018)

Radiological Association Between Multiple Sclerosis Lesions and Serum Vitamin D Levels
por: Akhtar, Ali, et al.
Publicado: (2022)

What is the Real Fate of Vitamin D in Multiple Sclerosis?
por: Shaygannejad, Vahid, et al.
Publicado: (2013)

Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes
por: Poutiainen, Pekka, et al.
Publicado: (2016)

Cell-specific and region-specific transcriptomics in the multiple sclerosis model: Focus on astrocytes
por: Itoh, Noriko, et al.
Publicado: (2018)

CCL5–Glutamate Cross-Talk in Astrocyte-Neuron Communication in Multiple Sclerosis
por: Pittaluga, Anna
Publicado: (2017)

Astrocyte metabolism in multiple sclerosis investigated by 1-C-11 acetate PET
por: Kato, Hiroki, et al.
Publicado: (2020)

Synaptic pathology in multiple sclerosis: a role for Nogo-A signaling in astrocytes?
por: Espírito-Santo, Sheila, et al.
Publicado: (2022)

Star power: harnessing the reactive astrocyte response to promote remyelination in multiple sclerosis
por: Junior, Markley Silva Oliveira, et al.
Publicado: (2023)

Modulation of NKG2D Expression in Human CD8(+) T Cells Corresponding with Tuberculosis Drug Cure
por: Hassan, Syeda S., et al.
Publicado: (2013)

Mitochondrial defects in acute multiple sclerosis lesions
por: Mahad, Don, et al.
Publicado: (2008)

Feasibility of Imaging Myelin Lesions in Multiple Sclerosis
por: Zavodszky, Maria I., et al.
Publicado: (2011)

Diffusivity in multiple sclerosis lesions: At the cutting edge?()
por: Klistorner, Alexander, et al.
Publicado: (2016)

The relevance of cortical lesions in patients with multiple sclerosis
por: Geisseler, Olivia, et al.
Publicado: (2016)

Diffusivity in the core of chronic multiple sclerosis lesions
por: Klistorner, Alexander, et al.
Publicado: (2018)

Multiple Sclerosis CD49d(+)CD154(+) As Myelin-Specific Lymphocytes Induced During Remyelination
por: Piatek, Paweł, et al.
Publicado: (2019)

Atypical Multiple Sclerosis Lesions or Progressive Multifocal Leukoencephalopathy Lesions: That Is the Question
por: De Mercanti, Stefania Federica, et al.
Publicado: (2020)

Retinal Astrocytic Hamartoma in Tuberous Sclerosis
por: Mishra, Chitaranjan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_huq2df16i9gbca7hreorlhj29p